Investor Patel Chirag K.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Patel Chirag K. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-08-08 13D/A AMRX / Amneal Pharmaceuticals, Inc. 21,835,007 22,180,421
2024-10-31 13D/A AMRX / Amneal Pharmaceuticals, Inc. 21,835,007 21,835,007
2023-11-08 13D/A AMRX / Amneal Pharmaceuticals, Inc. 21,835,007 21,835,007
2023-10-18 13D/A AMRX / Amneal Pharmaceuticals, Inc. 21,300,504 21,835,007
2019-09-11 13D/A AMRX / Amneal Pharmaceuticals, Inc. 21,300,504 21,300,504
2019-08-07 13D/A AMRX / Amneal Pharmaceuticals, Inc. 21,269,420 21,300,504
2018-07-09 13D AMRX / Amneal Pharmaceuticals, Inc. 21,269,420